Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice.
Outcome after traumatic brain injury (TBI) is worsened by hemorrhagic shock (HS), but the optimal resuscitation approach is unclear. In particular, treatment of TBI patients with colloids remains controversial. We hypothesized that resuscitation with the colloids polynitroxylated albumin (PNA) or Hextend (HEX) is equal or superior to resuscitation with the crystalloids hypertonic (3%) saline (HTS) or lactated Ringer's solution (LR) after TBI plus HS in mice. C57/BL6 mice (n = 30) underwent controlled cortical impact (CCI) and 90 min of volume-controlled HS (2 mL/100 g). The mice were randomized to resuscitation with LR, HEX, HTS, or PNA, followed by 30 min of test fluid administration targeting a mean arterial pressure (MAP) of >50 mm Hg. Shed blood was re-infused to target a MAP >70 mm Hg. At 7 days post-insult, hippocampal neuron counts were assessed in hematoxylin and eosin-stained sections to quantify neuronal damage. Prehospital MAP was higher, and prehospital and total fluid requirements were lower in the PNA and HEX groups (p < 0.05 versus HTS or LR). Also, 7-day survival was highest in the PNA group, but was not significantly different than the other groups. Ipsilateral hippocampal CA1 and CA3 neuron loss did not differ between groups. We conclude that the colloids PNA and HEX exhibited more favorable effects on acute resuscitation parameters than HTS or LR, and did not increase hippocampal neuronal death in this model.
Exo
Jennifer L
JL
Safar Center for Resuscitation Research, Pittsburgh, Pennsylvania, USA.
Shellington
David K
DK
Bayir
Hülya
H
Vagni
Vincent A
VA
Janesco-Feldman
Keri
K
Ma
Lil
L
Hsia
Carleton J
CJ
Clark
Robert S B
RS
Jenkins
Larry W
LW
Dixon
C Edward
CE
Kochanek
Patrick M
PM
D000418:Albumins / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001810:Blood Volume / Q000187:drug effects / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D001930:Brain Injuries / Q000188:drug therapy* / Q000503:physiopathology; D002452:Cell Count; D004195:Disease Models, Animal; D004632:Emergency Medical Services / Q000379:methods; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D006895:Hydroxyethyl Starch Derivatives / Q000494:pharmacology / Q000627:therapeutic use; D007022:Hypotension / Q000188:drug therapy / Q000503:physiopathology; D007552:Isotonic Solutions / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009410:Nerve Degeneration / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D012151:Resuscitation / Q000379:methods; D000077325:Ringer's Lactate; D012462:Saline Solution, Hypertonic / Q000494:pharmacology* / Q000627:therapeutic use; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015996:Survival Rate; D016896:Treatment Outcome
D000418:Albumins; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D000077325:Ringer's Lactate; D012462:Saline Solution, Hypertonic; C117059:polynitroxyl-albumin
J Cereb Blood Flow Metab. 2001 Jul;21(7):847-56
11435797
N Engl J Med. 2004 May 27;350(22):2247-56
15163774
Stroke. 2000 Apr;31(4):961-7
10754006
Crit Care Med. 1991 Mar;19(3):364-72
1705491
Acta Anaesthesiol Scand. 2007 Oct;51(9):1194-201
17711565
J Trauma. 2008 Feb;64(2):348-57
18301197
J Neurosurg. 1988 Jul;69(1):72-81
3379478
J Am Coll Surg. 2007 Feb;204(2):261-75
17254930
J Neurotrauma. 1996 Jul;13(7):371-83
8863193
J Neurosurg. 1992 Jan;76(1):91-8
1727174
Surg Neurol. 1993 Sep;40(3):196-206
8346473
J Trauma. 2004 Sep;57(3):547-54
15454801
J Cereb Blood Flow Metab. 2008 Jun;28(6):1114-26
18319733
J R Coll Surg Edinb. 1982 Sep;27(5):292-8
7143298
Neuroreport. 2001 Nov 16;12(16):3609-12
11733721
Neurosurg Focus. 2007 May 15;22(5):E5
17613236
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H167-75
16443674
J Cereb Blood Flow Metab. 1998 Sep;18(9):1022-31
9740106
Surgery. 2004 Aug;136(2):355-63
15300202
J Surg Res. 1991 Mar;50(3):284-92
1999918
Free Radic Biol Med. 1998 Jul 15;25(2):153-9
9667490
J Neurosurg. 1988 Jul;69(1):82-91
2454305
J Trauma. 2002 Nov;53(5):968-77
12435951
J Interferon Cytokine Res. 1999 Jul;19(7):791-5
10454350
Brain Res. 1989 Jan 16;477(1-2):211-24
2702484
Exp Neurol. 2002 Aug;176(2):355-63
12359177
J Neurotrauma. 2009 Jun;26(6):889-99
18781889
J Trauma. 1993 Feb;34(2):216-22
8459458
Free Radic Biol Med. 2002 Apr 15;32(8):712-9
11937297
N Engl J Med. 2007 Aug 30;357(9):874-84
17761591
Prehosp Emerg Care. 2008;12 Suppl 1:S1-52
18203044
J Trauma. 2003 Jul;55(1):94-105
12855887